LIXTE BIOTECHNOLOGY HOLDINGS, INC. Earnings Per Share Diluted

Quick Answer

LIXTE BIOTECHNOLOGY HOLDINGS, INC. reported Earnings Per Share Diluted of $1.26 (loss) per share for the year ending 2025.

  • LIXTE BIOTECHNOLOGY HOLDINGS, INC. showed an increase of +20.8% in Earnings Per Share Diluted from 2024 to 2025.
  • This data is from LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 4 years of available data (2022 to 2025), LIXTE BIOTECHNOLOGY HOLDINGS, INC.'s Earnings Per Share Diluted has grown by 68.4%.
  • Historical annual values: Fiscal year 2025: $1.26 (loss) per share | Fiscal year 2024: $1.59 (loss) per share | Fiscal year 2023: $2.66 (loss) per share | Fiscal year 2022: $3.99 (loss) per share.
  • Data sourced from SEC EDGAR public filings as of June 22, 2026.

Last verified: